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ABSTRACT 
 
ELIZABETH S. EVANS:  Cardiovascular and blood lactate responses to low, moderate, 
and high intensity aerobic exercise in breast cancer patients:  Is exercise intensity a true 
reflection of perceived exertion? 
(Under the direction of Claudio Battaglini, Ph.D.) 
 
Exercise prescription guidelines for breast cancer patients have yet to be 
established.  The purpose of this study was to compare the heart rate (HR), rate of 
perceived exertion (RPE), and post-exercise blood lactate responses to aerobic exercise 
between post-treated breast cancer patients and apparently healthy controls. Fourteen 
subjects (7 patients, 7 controls) participated in this study.  Three different exercise 
intensities (40%, 60%, and 70% of VO2max) were examined.  No differences were 
observed in HR, RPE, or post-exercise lactate for the exercise trials, with the exception of 
lactate after the exercise trial at 70% of VO2max, where the control group had a 
significantly higher response compared to the experimental group (p<0.0005).  Post-
treated breast cancer patients seem to respond similarly to these 3 exercise intensities 
compared with apparently healthy controls.  However, methodological challenges faced 
during this study should be addressed for a more clear understanding of the current 
findings. 
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CHAPTER I 
INTRODUCTION 
Breast cancer is the most common cancer in women, and the second leading cause 
of cancer deaths in women in the United States (Kim, Kang, Smith, & Landers, 2006).  
Treatment for breast cancer, including surgery, chemotherapy, and radiation therapy, can 
cause significant physical and psychological distress that may persist for months or years 
after the completion of therapy (Kim et al., 2006).  Fatigue is the most common physical 
distress experienced by breast cancer patients, affecting up to 70% of patients during 
therapy and up to 30% of patients years after the completion of therapy (Dimeo, 
Rumberger, & Keul, 1998).  This type of fatigue is often severe and may limit activities 
of daily living; therefore, many patients are advised to rest and reduce their level of daily 
activities (Dimeo et al., 1998).  However, inactivity leads to muscular atrophy, and 
prolonged rest can actually worsen fatigue, thus contributing to a cycle of further 
muscular atrophy and down-regulation of daily activity levels (Dimeo et al, 1998; Dimeo, 
Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999; and Segal et al., 2001).   
Aerobic exercise has been shown to improve physical performance in breast 
cancer patients (Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo et al., 
1998; Dimeo et al., 1999; Drouin et al., 2006; Fairey et al., 2003; Fairey, Courneya, 
Field, Bell, Jones, & Mackey, 2005; Fairey, Courneya, Field, Bell, Jones, St. Martin, et 
al., 2005; Kim, 2006, Mutrie et al., 2007; Nieman et al., 1995; Quist et al., 2006; Saxton 
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et al., 2006; and Segal et al., 2001).  Previous studies have described intervention 
programs ranging in intensities of 50-85% of maximal (peak) oxygen uptake VO2max(peak), 
maximum heart rate, or heart rate reserve, frequencies of 3-5 days per week, and 
durations of 8-26 weeks (Dimeo et al., 1997; Dimeo et al., 1998; Dimeo et al., 1999; 
Drouin et al., 2006; Fairey et al., 2003; Fairey, Courneya, Field, Bell, Jones, & Mackey, 
2005; Fairey, Courneya, Field, Bell, Jones, St. Martin, et al., 2005; Kim, 2006; Mutrie et 
al., 2007; Nieman et al., 1995; Quist et al., 2006; Saxton et al., 2006; and Segal et al., 
2001).  Significant increases in cardiovascular endurance and aerobic capacity, decreases 
in fatigue, and some improvements in blood parameters and immune function have been 
found (Dimeo et al., 1997; Dimeo et al., 1998; Dimeo et al., 1999; Drouin et al., 2006; 
Fairey et al., 2003; Fairey, Courneya, Field, Bell, Jones, & Mackey, 2005; Fairey, 
Courneya, Field, Bell, Jones, St. Martin, et al., 2005; Kim, 2006; Mutrie et al., 2007; 
Nieman et al., 1995; Quist et al., 2006; Saxton et al., 2006; and Segal et al., 2001). These 
choices for exercise intervention parameters, particularly intensity, are modeled after the 
current guidelines employed for cardiac patients.  In two recent reviews, Ko and 
McKelvie (2005) and Smart, Fang, and Marwick (2003) reported that most studies 
examining the effects of aerobic training on patients with heart failure have used 
intensities of 40%-80% VO2peak.  Additionally, many studies involving cardiac patients 
have also used heart rate (HR) and Borg’s rating of perceived exertion (RPE) as 
guidelines for aerobic exercise intensity.   Intensities ranging from 50-80% of HR 
reserve, 60-85% of predetermined peak HR, 40%-65% of maximal HR, and RPE ratings 
of 12-14 have successfully been used to study the effects of aerobic exercise on patients 
with heart failure (Corvera-Tindel, Doering, Woo, Khan, & Dracup, 2004; European 
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Heart Failure Training Group, 1998; Ko et al., 2005; Mairoana, O’Driscoll, Cheetham, 
Collis, Goodman, Rankin, et al., 2000; Oka, De Marco, Haskell, Batvinick, Dae, Bolen, 
et al., 2000; Smart et al., 2003; and Whellan, O’Connor, Lee, Keteylan, Cooper, Ellis, et 
al., 2007).  Other studies examining the effect of exercise on cardiac patients have also 
used blood lactate concentration and lactate threshold to describe exercise intensity as 
aerobic or anaerobic (Mertesdorf & Schmitz, 2005; and Meyer, Samek, Schwaibold, 
Westbrook, Hajric, & Beneke, 1997). 
In the cardiac patient population, it is thought that lower intensities of 40%-50% 
VO2max may be more advantageous than higher intensities of 70-80% VO2max because the 
former may reduce the risk of left ventricular dilation, minimizing stress on the left 
ventricular wall (European Heart Failure Training Group, 1998).  However, it is not yet 
known whether similar exercise intensities currently prescribed for breast cancer patients 
are the most appropriate for eliciting the desired physiological changes without 
compromising other physiological functions (i.e., the immune system).  Furthermore, it is 
not yet known whether the currently prescribed exercise intensity levels are even an 
accurate or consistent measure of a patient’s true level of exertion.  What is needed are 
models that describe physiological responses to differing levels of aerobic exercise for 
cancer patients compared to healthy controls, so that it may be determined whether the 
currently prescribed exercise intensities are an accurate measure of a patient’s true level 
of exertion, relative to their normal healthy counterparts.  The purpose of this study is to 
compare the response to low, moderate, and high intensity aerobic exercise in breast 
cancer patients and healthy controls, using three indicators of exercise intensity; i.e., HR, 
RPE, and post-exercise blood lactate.   
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Research Questions 
 Research Question 1):  Will there be a differing response in HR between breast 
cancer patients and healthy controls during a 9 minute low intensity (40% of VO2max) 
aerobic exercise bout? 
Research Question 2):  Will there be a differing response in RPE between breast cancer 
patients and healthy controls during a 9 minute low intensity (40% of VO2max) aerobic 
exercise bout? 
Research Question 3):  Will there be a differing response in post-exercise blood lactate 
between breast cancer patients and healthy controls after a 9 minute low intensity (40% 
of VO2max) aerobic exercise bout? 
Research Question 4):  Will there be a differing response in HR between breast cancer 
patients and healthy controls during a 9 minute moderate intensity (60% of VO2max) 
aerobic exercise bout? 
Research Question 5):  Will there be a differing response in RPE between breast cancer 
patients and healthy controls during a 9 minute moderate intensity (60% of VO2max) 
aerobic exercise bout? 
Research Question 6):  Will there be a differing response in post-exercise blood lactate 
between breast cancer patients and healthy controls after a 9 minute moderate intensity 
(60% of VO2max) aerobic exercise bout? 
Research Question 7):  Will there be a differing response in HR between breast cancer 
patients and healthy controls during a 9 minute high aerobic intensity (70% of VO2max) 
exercise bout? 
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Research Question 8):  Will there be a differing response in RPE between breast cancer 
patients and healthy controls during a 9 minute high intensity (70% of VO2max) aerobic 
exercise bout? 
Research Question 9):  Will there be a differing response in post-exercise blood lactate 
between breast cancer patients and healthy controls after a 9 minute high intensity (70% 
of VO2max) aerobic exercise bout? 
Research Hypotheses 
Hypothesis 1):  At a low intensity (40% of VO2max), there will be no significant 
difference in HR response between breast cancer patients and healthy controls during a 9 
minute aerobic exercise bout. 
Hypothesis 2):  At a low intensity (40% of VO2max), there will be no significant 
difference in RPE response between breast cancer patients and healthy controls during a 
9 minute aerobic exercise bout. 
Hypothesis 3):  At a low intensity (40% of VO2max), there will be no significant 
difference in post-exercise blood lactate response between breast cancer patients and 
healthy controls during a 9 minute aerobic exercise bout. 
Hypothesis 4):  At a moderate intensity (60% of VO2max), there will be no significant 
difference in HR response between breast cancer patients and healthy controls during a 9 
minute aerobic exercise bout. 
Hypothesis 5):  At a moderate intensity (60% of VO2max), there will be no significant 
difference in RPE response between breast cancer patients and healthy controls during a 
9 minute aerobic exercise bout. 
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Hypothesis 6):  At a moderate intensity (60% of VO2max), there will be no significant 
difference in post-exercise blood lactate response between breast cancer patients and 
healthy controls during a 9 minute aerobic exercise bout. 
Hypothesis 7): At a high intensity (70% of VO2max), breast cancer patients will exhibit a 
significantly higher HR response compared to healthy controls during a 9 minute aerobic 
exercise bout. 
Hypothesis 8):  At a high intensity (70% of VO2max), breast cancer patients will exhibit a 
significantly higher RPE response compared to healthy controls during a 9 minute 
aerobic exercise bout. 
Hypothesis 9):  At a high intensity (70% of VO2max), breast cancer patients will exhibit a 
significantly higher post-exercise blood lactate response compared to healthy controls 
after a 9 minute aerobic exercise bout. 
Definition of Terms 
Intensity:  The magnitude of stress being placed upon the body during exercise.  For 
aerobic exercise, intensity may be expressed as a percentage of maximum oxygen uptake 
(% of VO2max) 
Exertion: The physical effort performed by the body in response to an exercise intensity.   
Borg’s Rate of Perceived Exertion (RPE) Scale:  A category scale ranging from 6 to 20, 
where a rating of 6 is equivalent to “no exertion” and 20 is equivalent to “maximal 
exertion.”  Subjects are shown the scale at various intervals during an exercise test, and 
are instructed to point to the number on the scale which most closely describes how 
intensely they feel they are working at a given time. 
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Blood Lactate:  Accumulation of lactate in the bloodstream.  Lactate is produced by 
skeletal muscle as a byproduct of anaerobic glycolysis, and the amount produced by the 
skeletal muscle, which is then transported into the bloodstream, is directly proportional to 
exercise intensity. 
Predicted VO2max:  Maximum oxygen uptake (VO2max) calculated from the results of a 
submaximal exercise test.   
International Physical Activity Questionnaire (IPAQ):  a questionnaire used to assess a 
person’s current level of physical activity. 
Major Cancer Treatment: Surgery, chemotherapy, and radiation therapy. 
Adjuvant Trastuzumab Therapy:  A drug used to treat women with advanced breast 
cancer, particularly in tumors that over-express the human epidermal growth factor 
receptor 2 protein (HER2 protein).  Trastuzumab is also known as Herceptin. 
Post-Treated Breast Cancer Patients:  Patients within six months of completion of all planned 
surgery, radiation therapy, and chemotherapy. 
Get REAL & HEEL Breast Cancer Program:  An exercise/recreation therapy program designed to assist 
post-treated breast cancer patients in the management of side-effects commonly 
developed with cancer diagnosis and during cancer treatment. 
Healthy Controls:  Subjects who do not have a history of cancer treatment, and are not 
currently suffering from any activity-limiting illnesses.   
Control Group:  Consists of healthy controls recruited from the faculty, staff, and student 
populations at UNC-Chapel Hill.   
Experimental Group:  Consists of post-treated breast cancer patients currently enrolled in 
the Get REAL & HEEL Breast Cancer Program.   
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Assumptions 
1. All subjects enrolled in the study strictly followed the pre-exercise guidelines 
prior to reporting for exercise sessions. 
2. The impact of different cancer treatments and drugs resulted in similar side effects 
experienced by the subjects in the experimental group enrolled in the study. 
3. Subjects accurately answered the IPAQ. 
4. Subjects accurately reported RPE 
Delimitations 
1. All subjects were female. 
2. All subjects were within the ages of 30-75 years. 
3. Subjects in the experimental group voluntarily participated in the Get REAL & 
HEEL Breast Cancer Program and were residents in one of the 13 counties of the 
N.C. Triangle Affiliate of the Susan G. Komen Foundation. 
4. Subjects in the experimental group completed all major cancer treatment within 
six months. 
5. Subjects in the experimental group received permission from their oncology 
physician to enroll in the Get REAL & HEEL Breast Cancer Program. 
6. Subjects in the control group were recruited from the faculty, staff, and student 
populations at UNC-Chapel Hill. 
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Limitations 
1. All attempts were made to exactly age-match subjects in the experimental and 
controls groups.  If this was not possible, then subjects were matched within an 
age range.   
2. Similarly, it may be difficult to exactly match subjects in the experimental and 
controls for physical activity level.  All subjects in the control group were 
recruited based on the knowledge that they were not participating in a 
regular/structured physical activity program for at least the past 3 months. 
3. The submaximal test that was used to predict VO2max may present some 
measurement error since the subjects were not exercising to their actual VO2max, 
and because some subjects may have never used a treadmill before and may have 
felt uncomfortable performing the test. 
Significance of the Study 
Research hypotheses 1-6 of this study state that there will be no significant 
difference in HR, RPE, and post-exercise blood lactate responses between breast cancer 
patients and healthy controls at low and moderate exercise intensities.  Accepting these 
hypotheses would indicate that breast cancer patients and healthy controls exhibit similar 
exertion at low and moderate aerobic exercise intensities of 40% and 60% of VO2max, 
respectively, and that exercise interventions designed for the normal healthy population at 
these intensities may also be safe to use with the breast cancer patient population.  
Research hypotheses 7-9 state that there will be different responses in HR, RPE, and 
post-exercise blood lactate responses between breast cancer patients and healthy controls 
at a high intensity of 70% of predicted VO2max, with breast cancer patients exhibiting 
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greater responses than the healthy controls. Accepting these hypotheses would indicate 
that there is a potential threshold above which cardiovascular, RPE and blood lactate 
responses are different between breast cancer patients and healthy controls, and that 
prescribing exercise intensities at or above 70% of predicted VO2max for breast cancer 
patients may cause them to experience greater-than-desired exertion levels when 
compared to healthy matched controls, which should be seen cautiously when prescribing 
exercise at high intensity in post-treated breast cancer patients.  Therefore, accepting the 
research hypotheses of this study may significantly affect the way in which exercise 
intensities are measured and prescribed in the breast cancer patient population when 
considering exercise interventions after completion of major cancer treatment.  
  
 
CHAPTER II 
REVIEW OF LITERATURE 
The purpose of this study is to compare the response to low, moderate, and high 
intensity aerobic exercise in breast cancer patients and healthy controls, using various 
indicators of exertion; i.e., heart rate (HR), rate of perceived exertion (RPE), and post-
exercise blood lactate.  For the purpose of organization, this review of literature has been 
divided into three sections: 1) quantification of exercise intensity and exertion during 
aerobic exercise, 2) American College of Sports Medicine (ACSM) guidelines for 
intensities used for cardiopulmonary exercise prescription for the healthy adult, cardiac 
patient, and elderly populations, and 3) intensities to use when prescribing 
cardiopulmonary exercise in the breast cancer patient population.   
Quantification of Exercise Intensity and Exertion during Aerobic Exercise 
 Exercise intensity can be defined as the magnitude of stress being placed upon the 
body during exercise.  For aerobic exercise, intensity may be expressed as a percentage of 
maximum oxygen uptake (% of VO2max).  Quantification of exercise intensity is 
important when formulating exercise prescriptions for individuals ranging from clinical 
populations to athletes, because it gives an objective evaluation of performance and 
physiological measures (Brooks, Fahey, & Baldwin, 2005, p. 503).  An exercise specialist 
can monitor how an individual responds to various intensities during, immediately after, 
or several hours after an exercise session in order to evaluate which intensities do or do 
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not produce physiological changes that will help the individual reach his/her desired 
fitness goals.  Three parameters that are commonly used to quantify intensity and 
exertion during aerobic exercise are HR, RPE, and blood lactate. 
Heart Rate 
During aerobic exercise, HR increases in a relatively linear fashion with exercise 
intensity and oxygen consumption (Brooks et al., 2005, p. 345; Whaley, Brubaker, & 
Otto, 2006, p. 143).  In the context of a training program, HR can be used to quantify 
intensity during an exercise session, as well as adequacy of recovery after the session is 
complete (Brooks et al., 2005, p. 503).  Using HR to quantify intensity also gives an 
immediate and objective measure of how the body responds to a particular workload 
during exercise training.  When writing an exercise prescription, target HR (THR), 
corresponding to a particular exercise intensity, can be calculated by three different 
methods: either directly, as a percentage of maximum HR, or by the HR reserve (HRR) 
method (Whaley et al., 2006, pp. 144-146). 
In order to use the direct method to calculate a THR range corresponding to a 
particular exercise intensity range, a plot of HR as a function of VO2 is created.  These 
values can be measured during a VO2max test, during which both VO2max and maximum 
HR could be determined (Whaley et al., 2006, pp. 144-145).  One can then calculate a 
range of percentage of VO2max and then find the corresponding HR range on the plot.  
This HR range would correspond to the THR range for the exercise prescription.  This 
method is especially appropriate for certain populations, such as cardiac rehabilitation 
patients who may be taking medications which may affect the HR response to exercise 
(Whaley et al., 2006, pp. 144-145). 
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The second method for calculating THR range is to calculate the maximum HR 
for an individual and then calculate straight percentages of those values (Whaley et al., 
2006, p. 144).  Intensity ranges of 70-80% of maximum HR approximate 50-70% 
VO2max, which is within the range to stimulate improvements in VO2max for most 
individuals (Whaley et al., 2006, p. 144).  However, this method can an inaccurate 
quantification of lower intensities because a THR at a low percentage of maximum HR 
may yield a result that is actually below the resting HR (Whaley et al., 2006, p. 144). 
A third method for calculating THR range is to use the HRR method, also known 
as the Karvonen method (Whaley et al., 2006, pp. 144-145).  Target HR is calculated by 
using the Karvonen formula, where THR = (220-age-resting HR)*(% intensity) + resting 
HR (Brooks et al., 2005, p. 713; Whaley et al., 2006, pp. 144-145).  This method is often 
preferred for calculating exercise intensity ranges for an exercise prescription because it 
is closely linked to percentage of VO2 reserve (the difference between VO2max and resting 
VO2) across the entire range of fitness levels, an important point when considering 
individuals of lower fitness levels (Whaley et al., 2006, p. 145). 
Rate of Perceived Exertion 
 Exertion can be defined as the physical effort performed by the body in response 
to a particular exercise intensity.  An individual’s perception of exertion is considered to 
be a combination of sensations involving the muscles, joints, cardiopulmonary system, 
and the central nervous system during exercise, and may include factors such as HR, 
oxygen uptake, respiration rate, minute ventilation, blood lactate concentration, blood 
pH, mechanical strain, skin temperature and core temperature (Borg, 1990; Groslambert 
& Mahon, 2006).  Borg (1990) has shown that perception of exertion increases as 
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physical workload increases for several modes of aerobic exercise including cycle 
ergometry, running, walking, and arm cranking.   
In order to quantify perceived exertion, Borg (1982, 1990) has developed a 15-
point scale, commonly named the Borg’s Rate of Perceived Exertion (RPE) scale.  This 
scale was initially constructed to increase linearly with exercise intensity, HR and power 
output on the cycle ergometer, (Borg, 1982, 1990; Groslambert et al., 2006).  Borg’s RPE 
scale displays values that range from 6 to 20, where a value of 6 represents “no exertion” 
and a value of 20 represents “maximal exertion” (Borg, 1982).  Descriptive phrases 
including “very light”, “somewhat hard”, and “very hard” are also included on the scale.  
The scale’s range of values from 6 to 20 can be used to denote heart rates ranging from 
60 to 200 beats per minute (Borg, 1982).  This was intended to make the scale easier to 
use because by knowing an individual’s RPE score, one could make an estimation of HR 
during exercise.  However, it is difficult to exactly match a certain RPE score to a certain 
HR because HR at a given exercise workload can depend on a multitude of factors such 
as age, type of exercise, environment, and anxiety (Borg, 1982).  Borg’s RPE scale has 
become a very popular method of quantifying exercise intensity, and has therefore been 
translated into many languages (Borg, 1982).   
While perceived exertion ratings obtained from Borg’s RPE scale do parallel 
physiological variables that increase linearly with exercise (i.e. HR), this may not always 
be the case for physiological variables that do not increase linearly with exercise (Borg 
1982, 1990; Noble 1983).  Therefore, Borg and associates have also developed a 
category-ratio scale (Borg’s CR10 scale) that is appropriate for measuring sensations that 
may arise from physiological variables that grow exponentially such as blood lactate or 
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pulmonary ventilation (Borg 1982, Borg 1990, Noble, 1982; Groslambert et al., 2006).  
The CR10 scale displays values that range from 0 to 10, where a value of 0 is described 
as “nothing at all,” while a value of 10 is “very, very strong” (Borg, 1982).  Verbal 
expressions are placed next to the values on the scale according to ratio properties, such 
that a value of 1 (very weak) represents twice the intensity of a value of 0.5 (very, very 
weak); a value of 2 (weak) represents twice the intensity of a value of 1, and so on (Borg, 
1982).   
The simplicity of Borg’s RPE scale and the high correlation between RPE and 
exercise workload have also made it a popular tool for controlling intensities in clinical 
populations, such as in the cardiac rehabilitation patient population (Noble, 1982).  Using 
perceived exertion rating to quantify exercise intensity could be beneficial in this 
population particularly when the use of certain medications may have altered HR 
responses to exercise (Whaley, Brubaker, Kaminsky, & Miller, 1997; Whaley et al., 
2006, p. 146).  Borg and associates have also developed a 9-point scale for cardiac 
patients to use when rating angina pectoris during graded exercise tests which is similar 
to the RPE scale (Noble, 1982).   Within the context of exercise prescription, perceived 
exertion is a useful tool because it is closely related to HR, but it also integrates other 
important strain variables (Borg, 1982). 
Blood Lactate 
Lactate is produced by skeletal muscle as a byproduct of anaerobic glycolysis, and the 
amount produced by the skeletal muscle, which is then transported into the bloodstream, 
is proportional to exercise intensity.  Blood lactate refers to the accumulation of lactate in 
the bloodstream.  A blood lactate concentration of 4 mmol/L is often considered to be the 
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lactate threshold, the level at which lactate production mechanisms surpass lactate 
clearance mechanisms, and blood lactate levels begin to rise exponentially (Brooks et al., 
2005, pp. 503-504).  Intensities that elicit lactate production above the lactate threshold 
become difficult to maintain for extended periods of time and contribute to fatigue.  
Although 4 mmol/L is often synonymous with the lactate threshold, exercise training can 
push this threshold to higher levels. 
Relationship between HR, RPE, and Blood Lactate 
 Several studies have investigated the relationship between HR, RPE, and blood 
lactate as measures of aerobic exercise intensity.  Noble, Borg, Jacobs, Ceci, and Kaiser 
(1983) examined the relationship between perceived exertion ratings from Borg’s CR10 
scale with blood and muscle lactate levels and HR.  Ten physically active males rode a 
cycle ergometer until voluntary exhaustion while HR, RPE, and lactate levels were 
measured.  The results showed that RPE, HR, and lactate all increased with increasing 
exercise intensity; HR increased linearly while RPE and blood lactate increased as a 
quadratic function of intensity.   
Borg, Ljunggren, and Ceci (1985) examined the relationship between perceived 
exertion, perception of aches and pains in the legs, HR, and blood lactate during bicycle 
ergometry.  Twenty-eight healthy males performed an incremental exercise bout on the 
cycle ergometer, where workload was increased by 40 Watts every 4 minutes until 
voluntary exhaustion.  Heart rate, RPE (on both the Borg’s 6-20 point scale and the CR10 
scale), and blood lactate were recorded during the last minute of each workload stage, as 
well as at the point when the subjects terminated the test.  The results showed that HR 
increased linearly as a function of workload, while RPE, perception of aches and pains in 
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the legs, and blood lactate increased exponentially.  Correlation coefficients between HR, 
RPE, perception of aches and pains in the legs, and blood lactate were high, particularly 
during the higher workloads of the test. 
In a similar study, Borg, Hassmen, and Lagerström (1987) compared HR, RPE, and 
blood lactate responses to arm crank ergometry with those from cycle ergometry in 8 
healthy males.  Exercise bouts involved stepwise increases in intensity of 40-70-100-150-
200 Watts for the cycle ergometer, and 20-35-50-70-100 Watts for the arm crank 
ergometer.  The subjects exercised at each intensity in 4 minute increments, and at the 
end of each increment, HR, blood lactate, and RPE (on both the Borg’s 6-20 point scale 
and the CR10 scale) were measured.  Heart rate and RPE scores from Borg’s 6-20 point 
scale showed linear increases as a function of exercise intensity for both cycling and arm 
cranking, while blood lactate and RPE scores from Borg’s CR10 scale showed 
exponential increases as a function of exercise intensity for both cycling and arm 
cranking.  A plot of RPE response from Borg’s 6-20 point scale and RPE from the CR10 
scale as a function of HR showed nearly-linear relationships, as did RPE responses as a 
function of blood lactate.  A separate analysis was done to investigate the relationship 
between RPE response from the CR10 scale as a function of a combined HR-blood 
lactate response, which also showed a positive linear relationship. 
Green, McLester, Crews, Wickwire, Pritchett, and Lomax (2006) examined the 
relationship between HR, RPE, and blood lactate responses during repeated high-
intensity interval cycling.  Twelve physically active males completed a series of high 
intensity cycling bouts at a workload above what was needed to elicit a 4 mmol/L blood 
lactate response.  The intervals consisted of five 2-minute periods of high-intensity 
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cycling followed by 3 minutes of recovery cycling Heart rate, RPE (using Borg’s 6-20 
point scale), and blood lactate were measured at the end of each 2-minute high intensity 
cycling period and also at the end of each 3-minute recovery cycling period.  Significant 
correlations were found for HR and RPE response as well as blood lactate and RPE 
response during both the high-intensity period and the recovery period of the interval. 
Irving et al. (2006) studied the utility of two different RPE scales as markers of the 
blood lactate response to exercise in 26 females and 10 males with the metabolic 
syndrome.  Subjects completed a treadmill protocol to determine VO2peak and lactate 
threshold.  Subjects began walking on a treadmill at 60 m/min, which was increased by 
10 m/min in 3 minute stages until volitional fatigue.  Heart rate and blood lactate were 
measured at the end of each stage, and RPE scores, using Borg’s 6-20 point scale and the 
OMNI walk/run 0-10 point scale, were measured at 2:15 and 2:45 of each stage.  The 
correlation coefficients within and between the two RPE scales and the treadmill speeds 
associated with the lactate threshold, blood lactate concentrations of 2.5 mmol/L, 4.0 
mmol/L, and peak were 0.82-0.93 (p<0.01).  These results indicate that RPE can 
contribute to the prediction of the blood lactate response to incremental exercise. 
ACSM Guidelines for Intensities to use for Cardiopulmonary Exercise Prescription 
 As mentioned previously, several studies have shown that aerobic exercise can 
improve physical performance in the breast cancer patient population.  The current 
recommendations for cardiopulmonary exercise prescription in cancer patients are 
somewhat similar to the ACSM guidelines for exercise prescription in healthy adults; 
however, they are largely modeled after the current ACSM guidelines for exercise 
prescription in the cardiac patient population and the elderly adult population.  This 
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section will discuss the current ACSM guidelines for cardiopulmonary exercise 
prescription in the healthy adult population with respect to exercise intensity, followed by 
a discussion of the current ACSM guidelines for cardiopulmonary exercise prescription 
in cardiac patients and the elderly. 
Healthy Adult Population 
 When creating exercise prescriptions for the healthy adult population, the ACSM 
recommends intensity ranges of 40 or 50% to 85% of oxygen uptake reserve (VO2R) or 
HRR, or 64 or 70% to 94% of maximum HR (Whaley et al., 2006, p. 141).  This broad 
range in intensities reflects the fact that lower fitness individuals can demonstrate 
improved cardiopulmonary fitness when exercising at only 40-50% HRR or 64-70% 
maximum HR (Whaley et al., 2006, p. 141).  Even intensities of 30% of VO2R can elicit 
improvements in VO2max for people with a VO2max less than 40 mL/kg/min (Whaley et 
al., 2006, p. 141).  However, for individuals with a VO2max greater than 40 mL/kg/min, 
exercise intensities above 45% VO2R should be used in order to stimulate an increase in 
VO2max, and for individuals who already participate in regular physical activity, exercise 
intensities at the high end of the recommended range are needed to further elicit 
improvements in VO2max (Whaley et al., 2006, p. 141).  Most individuals can achieve an 
increased VO2max with intensities of 60-80% HRR or 77-90% of maximum HR when 
combined with an appropriate training frequency and duration (Whaley et al., 2006, p. 
141). 
 The ACSM also recommends that an RPE range of 12-16 on the Borg RPE scale 
should be incorporated into the exercise prescription in order to stimulate physiological 
adaptations to exercise (Whaley et al., 2006, p. 146).  This corresponds to a perceived 
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exertion of “somewhat hard” to “hard.” (Borg, 1982).  However, it is important to note 
that there can be some variation with how exertion is perceived among individuals.  
Therefore, it should be expected that RPE for different modes of exercise may not be the 
same, and that RPE may not always exactly match the intensity determined by heart rate 
methods (Whaley et al., 2006, p. 146). 
Cardiac Patient Population 
 Cardiac rehabilitation exercise programs are designed to help patients return to 
their previous vocational and recreational activities, sometimes with the need to modify 
or find alternate activities (Whaley et al., 2006, p. 178).  They also provide patients with 
a safe and effective formal exercise program, and they educate patients and their families 
about cardiovascular disease risks and therapies to increase prevention of future cardiac 
events (Whaley et al., 2006, p. 178).  Cardiopulmonary exercise prescription in this 
population is generally similar to that in the healthy adult population with regard to 
exercise frequency and duration; while most of the modifications are with regard to 
exercise intensity (Whaley et al., 2006, p. 178). 
 The goals for determine the appropriate aerobic exercise intensities to use in the 
cardiac patient population are largely twofold:  1)  determine the minimum intensity that 
will produce a training effect, and 2) set a safe, upper limit intensity in order to prevent 
signs and symptoms representative of an intolerance to exercise (i.e., angina, abnormal 
blood pressure increase or decrease, abnormal ECG findings, left ventricular wall motion 
abnormalities, and increased ventricular dysrhythmias) (Whaley et al., 2006, p. 178).  
Intensities above 45% of VO2R have been shown to increase VO2max in cardiac patients 
(Whaley et al., 2006, pp. 179-180).   Because percent intensity of VO2R approximates 
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percent intensity of HRR, calculating THR ranges using the Karvonen method is widely 
used when prescribing intensity, and it is effective even for patients who may be taking 
medications that can alter the HR response to exercise (Whaley et al., 2006, p. 179).  
However, one cannot always rely solely on HR when prescribing exercise intensity; other 
variables must be considered, such as onset of angina, blood pressure response to 
exercise, ST-segment depression, dysrhythmias, and perceived exertion (Whaley et al., 
2006, p. 180). 
 Measuring RPE scores along with HR response can be very useful when 
prescribing cardiopulmonary exercise intensity, especially if a patient is entering a 
rehabilitation program without having done a baseline exercise test, or if clinical status 
and medical therapies change (Whaley et al., 2006, p. 180).  During the initial phases of 
rehabilitation, the ACSM also recommends that an RPE range of 11-13 on the Borg RPE 
scale should be incorporated into the exercise prescription (Whaley et al., 2006, p. 180).  
This RPE range corresponds to a perceived exertion of “fairly light” to “somewhat hard” 
(Borg, 1982).  During the later stages of rehabilitation, an RPE range of 14-16 
(“somewhat hard” to “hard”) may be used provided that patients do not exhibit signs and 
symptoms of ischemia or serious dysrhythmia (Borg, 1982; Whaley et al., 2006, pp. 180-
181).  However, it is important to note that events such as ischemic ST segment 
depression or serious ventricular dysrhythmias can occur at a low HR or RPE, indicating 
that exercise intensity should be closely monitored in this population (Whaley et al., 
2006, pp. 180-181).  Even so, cardiac patients should be encouraged to improve their 
exercise capacity through moderate-intensity exercise programs, and provided there are 
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no contraindications, work towards being able to perform more vigorous exercise 
(Whaley et al., 2006, p.181). 
Elderly Population 
 The current ACSM guidelines for prescribing cardiopulmonary exercise intensity 
in the healthy adult population generally apply to the elderly population (Whaley et al., 
2006, p. 248).  In order to minimize medical problems and promote long-term 
compliance, initial exercise intensities below 40% of VO2R or HRR are not uncommon, 
particularly for inactive elderly adults (Whaley et al., 2006, p. 248).  When quantifying 
intensity, using a measured peak HR may be preferable to using an age-predicted peak 
HR because of the variability in peak HR in adults older than 65 years and the increased 
risk of underlying coronary artery disease (Whaley et al., 2006, pp. 248-249).  
Additionally, elderly adults may be more likely to be taking medications that can affect 
the HR response to exercise (Whaley et al., 2006, p. 249). 
Intensities to use when prescribing Cardiopulmonary Exercise in the Breast Cancer 
Patient Population 
Cardiopulmonary Exercise during Treatment 
 The first studies examining the effect of cardiopulmonary exercise in breast 
cancer patients during treatment have occurred only within the past 20 years.  These 
studies primarily focused on outcomes such as changes in fatigue, VO2max, and quality of 
life.  In this body of literature, the reporting of exercise intensity is not always clear or 
consistent, due to the fact that many of the prescribed interventions were self-paced or 
home-based, the range of intensities used was quite large, and the quantification of 
exercise intensity varied from study to study. 
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There are several studies in which percentage of maximum HR was used to 
quantify exercise intensity in order to examine the effects of cardiopulmonary exercise on 
various factors such as physical function, performance, fatigue, treatment-related side-
effects, nausea, body composition, psychological well-being, and quality of life in breast 
cancer patients undergoing treatment.  In two studies, Winningham and MacVicar(1988), 
and Winningham, MacVicar, Bondoc, Anderson, and Minton (1989) investigated the 
effect of an exercise program on nausea, body weight, and body composition.  The first 
study included 42 breast cancer patients and the second study included 24 breast cancer 
patients, and in both studies, patients participated in an exercise program which included 
cycling at intensities of 60-85% of maximum HR.  MacVicar, Winningham, and Nickel. 
(1989) investigated the effects of aerobic interval training on functional capacity in 45 
breast cancer patients, which also included an exercise program where patients cycled at 
intensities of 60-85 % of maximum HR.  Dimeo et al. (1998) used an intensity of 80% of 
maximum HR to examine the effect of treadmill walking on fatigue and performance in 5 
cancer patients (including 1 breast cancer patient).  Campbell, Mutrie, White, McGuire, 
and Kearney (2005) conducted a pilot study to investigate the effects of aerobic exercise 
as an adjunct therapy for women receiving chemotherapy and radiation therapy for early 
stage breast cancer.  In this study, 19 patients participated in supervised aerobic exercise 
at intensities of 60-75% of maximum HR.  Mock et al. (2005) conducted a multi-
institutional randomized controlled trial to determine the effects of exercise on fatigue 
levels in 119 breast cancer patients, for which a home-based walking program at 50-75% 
of maximum HR was used.  Mutrie et al (2007) also used intensities of 50-75% of 
maximum HR to study the effect of a 12-week supervised group exercise program on 177 
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breast cancer patients after 6 months of follow-up.  The outcomes of these studies all 
showed positive changes in physical function parameters including increased VO2max, 
increased walking distance within a given period of time, and decreased HR and blood 
lactate during submaximal exercise.  Other positive changes including decreased fatigue, 
nausea, increased satisfaction with life, increased lean body mass, and decreased body fat 
were also observed. 
Other studies have used percentage of HRR to quantify intensity in order to study 
the effects of cardiopulmonary exercise on similar factors discussed previously.  Two 
studies by Dimeo et al. (1997, 1999) investigated the effects of physical exercise on 
physical performance, severity of treatment complications, and psychological distress in 
cancer patients.  In the first study, 70 patients (including 46 breast cancer patients) 
participated in an exercise program that included cycling at 50% of HRR, and in the 
second study, 59 patients (including 31 breast cancer patients) participated in an exercise 
program that included interval cycling, also at 50% of HRR.  Both studies revealed 
positive results, including increased physical performance and decreased thrombopenia, 
neutropenia, psychological distress, and time spent in the hospital. 
A third group of studies have used exercise interventions that are described as 
home-based and self-paced, which do not always clearly state how intensity was 
quantified.  Mock et al. (1997, 2001), Schwartz (1999, 2000), and Schwartz, Mori, Gao, 
Nail, and King (2001)  investigated the effect of home-based, self-paced walking 
programs on physical function, fatigue, treatment-related symptoms, and emotional 
distress in cohorts of 27 to 72 breast cancer patients during treatment.  The intensities 
used in these studies are not clearly defined; however, the investigators do report 
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improvements in 12-minute walk distance and decreases in fatigue and emotional 
distress.   
Lastly, there are several studies that have used percentage of VO2max to quantify 
cardiopulmonary exercise intensity.  Segal et al. (2001) investigated the effect of a self-
paced walking intervention along with a supervised exercise program at 50-60% of 
VO2max on physical function in 123 breast cancer patients.  Increased physical function, 
measured by the Short Form (SF)-36 scale were observed after 26 weeks of exercise 
intervention.  In patients who did not receive chemotherapy, aerobic capacity was 
significant increased and body weight was significantly decreased (p=0.01 and <0.05, 
respectively) in patients participating in supervised exercise compared with patients 
receiving usual care.   
In a study by Battaglini, Bottaro, Campbell, Novaes, and Simăo (2004), a group 
of 27 patients including 22 breast cancer patients participated in an exercise program 
where aerobic exercise intensity was set between 50-55% of maximal heart rate. The goal 
of the study was to examine the relationship between changes in selected physiological 
parameters and fatigue during a period of 6 months. Even though no significant 
relationship between selected physiological parameters including % body fat, resting 
heart rate, and dynamic endurance tests, an improvement in cardiorespiratory endurance 
of approximately 30% was observed with no adverse effects of the intensity used being 
reported.  
Battaglini et al. (2006) investigated the exercise response in a group of 20 breast 
cancer patients undergoing treatment. Patients assigned to the exercise group, participated 
in a structured exercise program at an intensity range between 40-60% of VO2max, for a 
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period of approximately 21 weeks. No adverse effects of the intensity used in this study 
were reported. Furthermore, significant decreases in fatigue were observed in the exercise 
group when compared to the control group at the end of the first, second, and final bout 
of chemotherapy treatment (p=.001, p=.005, and p=.001 respectively). 
Courneya et al. (2007) conducted a multicenter trial to study the effects of 
exercise on body composition, physical function, and quality of life.  This study included 
78 breast cancer patients who performed aerobic exercise at an intensity range of 60-80% 
of VO2max, using the treadmill, elliptical, and cycle ergometer.  Increased physical 
function was observed, as well as increased aerobic fitness, increased self esteem, 
improved body composition, and chemotherapy completion rate without causing 
lymphadema or other significant adverse events. 
Cardiopulmonary Exercise after Treatment 
 Studies examining the effect of cardiopulmonary exercise on breast cancer 
patients after the completion of treatment focus on many of the same outcomes as studies 
conducted during treatment.  In addition, endpoints relating to changes in endocrine and 
immune function are introduced.  In many of these studies, exercise intensities are better 
defined, and most utilize a percentage of maximum HR or percentage of VO2peak to 
quantify intensity. 
 Peters, Lötzerich, Niemeier, Schüle, and Uhlenbruck (1994, 1995) conducted two 
studies examining the effects of aerobic exercise training on immune function, 
psychological behavior, depression, and anxiety symptoms in 24 post-treated breast 
cancer patients.  Patients cycled at 60% of maximum HR during the aerobic portion of 
the exercise program.  The investigators found no change in natural (NK) cell number, 
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although there was an increase in NK cell cytotoxic activity.  Changes in other immune 
function parameters included an increase in granulocytes, and a decrease in lymphocytes 
and monocytes with some increased phagocytic activity in monocytes.  Positive changes 
were also reported for psychological parameters, particularly an increased satisfaction 
with life. 
 Nieman et al (1995) investigated the effect of exercise training on NK cell activity 
in 12 post-treated breast cancer patients.  The aerobic portion of the exercise training 
included walking on an indoor track at 75% of maximum HR.  The results showed that 
patients improved the distance walked during the 6 minutes walk test, while there were 
no changes in circulating NK cells or NK cell activity. 
 Segar et al. (1998) evaluated the effect of 10 weeks of aerobic exercise on 
depressive and anxiety symptoms and self esteem in 24 post-treated breast cancer 
patients.  Patients participated in cardiovascular exercise at 60% of maximum HR.  After 
10 weeks, patients reported a decrease in depression and anxiety. 
 Pinto, Frierson, Rabin, Trunzo, and Marcus (2005) examined the efficacy of a 
home-based physical activity intervention for 86 patients who had completed treatment 
for early-stage breast cancer.  Patients participated in a home-based self-directed exercise 
program that promoted activities such as biking, swimming, walking, and use of home 
exercise equipment.  Patients were instructed to perform these activities at a moderate 
intensity corresponding to 55-65% of maximum HR.  The results showed positive 
changes included a decrease in fatigue, improvements in mood and self esteem, and an 
increase in energy expenditure and total minutes spent performing physical activity. 
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 Several recent studies have turned to using a percentage of VO2peak(max) in order to 
quantify cardiopulmonary exercise intensity.  Fairey et al. (2003, 2005a, 2005b) 
conducted three studies examining the effect of exercise training on several blood 
markers including fasting insulin, insulin resistance, insulin growth factors, insulin 
growth factor binding proteins, NK cell cytotoxic activity, C-reactive protein, and various 
cardiovascular disease risk factors.  Fifty-two post-menopausal post-treated breast cancer 
patients participated in an exercise program that included cycling at 70-75% of VO2peak.  
Positive changes were observed for cardiovascular function and disease risk factors, 
including increased VO2max, and decreased C-reactive protein, resting HR, HRR, blood 
pressure, and HDL-C.  An increase in NK cell activity was also observed as well as 
changes in levels of insulin-like growth factors and insulin-like growth factor binding 
proteins.   
 Kim et al. (2006) studied cardiopulmonary responses and adherence to exercise 
after an 8-week exercise intervention in 41 post-treated breast cancer patients.  Patients 
participated in supervised aerobic exercise at an intensity of 60-70% VO2peak and/or HRR.  
Activities consisted of cycling, walking, or jogging on a treadmill.  The adherence to the 
exercise program was 78.3%, and the results showed that patients participating in 
exercise had decreased resting HR, resting systolic blood pressure, and an increased 
VO2peak.  Patients also reported an increase in voluntary activity, a decrease in sedentary 
activity. 
Cardiopulmonary Exercise Intensity as a Reflection of Exertion 
 From this review of literature, it is evident that the quantification of 
cardiopulmonary exercise intensity in the breast cancer patient population is inconsistent 
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(self-paced, percentage of maximum HR, HRR, or VO2peak(max))and a wide variety of 
intensities have been used (50-85%).  While many positive changes in psychological and 
cardiovascular parameters have been observed, the effect of exercise training on immune 
parameters (i.e., lymphocytes, NK cells, etc.)  is not yet clear.  Additionally, literature 
reporting perceived exertion scores and blood lactate responses in the breast cancer 
patient population is scarce.  Therefore, the present study is significant in that it compares 
HR, RPE, and blood lactate responses to a broad selection of aerobic intensity levels in 
both breast cancer patients and healthy controls.
  
 
CHAPTER III 
METHODOLOGY 
Subjects 
This was a thesis study with the goal of comparing three indicators of exertion 
(i.e., HR, RPE, and post-exercise blood lactate) in response to low, moderate, and high 
intensity aerobic exercise in breast cancer patients and healthy controls.  There were two 
study groups:  a group comprised of women who were post-treated breast cancer patients 
(experimental group) and a control group comprised of apparently healthy age-matched 
women.  Subjects in the experimental group were breast cancer patients who were post-
treatment and have been enrolled in the Get REAL & HEEL Breast Cancer Program at 
UNC-Chapel Hill.  Subjects in the control group were women recruited from the faculty, 
staff, and student populations at UNC-Chapel Hill, must not have been enrolled in regular 
organized physical activity during the past three months, and healthy enough to 
participate in aerobic exercise. All attempts were made to match subjects in both groups 
based on age and physical activity level.  The sample size for this study was 14 subjects, 
with 7 subjects in each group. 
The criteria for participation in the study for the experimental group are presented 
below: 
1. Confirmed diagnosis of Stage I, II, or III invasive breast cancer;  
2. Within 6 months of completion of all major cancer treatment; 
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3. Ages ranging from 30 to 75 years; 
4. Patients receiving adjuvant hormonal therapy or adjuvant trastuzumab were 
eligible; 
5. No presence of metastatic disease; 
6. No presence of immune deficiency that would compromise the subject’s ability to 
participate in regular exercise ; 
7. Be enrolled in the Get REAL & HEEL Breast Cancer Program. 
Participation in this study involved the same risks as any exercise regimen. Given the 
potential risks involved, all potential participants (both experimental and control group 
subjects) completed a comprehensive medical history questionnaire, and were thus 
screened for exclusion based upon the criteria listed below: 
1. Cardiovascular disease (unless the disease would not compromise the subject’s 
ability to participate in the exercise rehabilitation program); 
2. Acute or chronic respiratory disease (unless the disease would not compromise 
the subject’s ability to participate in the exercise rehabilitation program); 
3. Acute or chronic bone, joint, or muscular abnormalities that would compromise 
the subject’s ability to participate in the exercise rehabilitation program. 
Demographic Parameters 
Age, race, menopausal status, height, weight, percent body fat, and current 
physical activity level were recorded for all subjects upon enrollment onto the study.  
Height and weight were be used to calculate body mass index (BMI).  Menopausal status 
was assessed by asking subjects if they would classify themselves as pre-, peri-, or post-
menopausal.  For subjects in the experimental group, menopausal status before beginning 
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major cancer treatment was recorded.  Percent body fat was estimated using the Pollock 
3-site (triceps, suprailiac, and abdomen) skinfold measurement formula for women 
(Whaley et al., 2006, p. 63).  Current physical activity was assessed using the 
International Physical Activity Questionnaire (IPAQ).  For the subjects in the 
experimental group, breast cancer stage and type of treatment received was also recorded. 
Procedure 
 Each subject participated in a total of 4 sessions, including an initial assessment 
and 3 aerobic exercise sessions, one at each prescribed aerobic intensity (40%, 60%, and 
70% of VO2max).  All subjects were asked to follow a set of pre-assessment guidelines 
before each session, which are as follows: 
1.  No eating for at least 2 hours prior to testing. 
2.  No exercise for at least 12 hours prior to testing. 
3.  Subjects should maintain adequate hydration status. 
4. Subjects should refrain from caffeine use for at least 12 hours prior to testing. 
5. Subjects should refrain from alcohol use for at least 48 hours prior to testing. 
6. Subjects should refrain from using diuretic medications for at least 7 days prior to 
testing.   
All sessions took place in either the Get REAL & HEEL facilities or in the Applied 
Physiology Laboratory (APL) in the Department of Exercise and Sport Science at UNC-
Chapel Hill.  For the subjects in the experimental group, these sessions comprised a 
portion of the aerobic exercise segment of their training session for that day at Get REAL 
& HEEL.  The period of time from the initial assessment to the last exercise session was 
approximately 1-2 weeks. 
 33 
Initial Assessment 
 The Initial Assessment for each subject was conducted in the APL.  The Modified 
Bruce Submaximal Treadmill Protocol was used to predict VO2max for each subject.  This 
was a multistage protocol, where each stage lasted 3 minutes in duration with incremental 
increases in both treadmill speed and grade.  The assessment was terminated when a 
subject’s HR reaches a target heart rate of 75% of HRR, calculated using the Karvonen 
formula.  Heart rate and RPE were recorded at the end of each stage.  Borg’s Rate of 
Perceived Exertion Scale (6 to 20 point scale) was used to quantify RPE.  The time it 
took for the subject to complete the assessment was recorded upon termination, and this 
was used to calculate the predicted the predicted VO2max for each subject, using the 
following equation: 
VO2max = 2.282*(time) + 8.545 (Heyward, 2006, p. 68) 
After calculating predicted VO2max for each subject, the training intensities of 
40%, 60% and 70% of VO2max were calculated for each subject.  To calculate the 
treadmill speed and grade that corresponded to 40%, 60%, and 70% of VO2max, the 
horizontal and vertical components of VO2 were given equal weights of 50% and 50%, 
respectively.  
Aerobic Exercise Sessions 
 As mentioned previously, each subject participated in 3 aerobic exercise sessions, 
one at each intensity (40%, 60%, and 70% of VO2max).  Each session consisted of a 
warm-up/stretch period, an exercise trial, and a cool-down period.  The warm-up/stretch 
period was approximately 10 minutes in duration and was standard for all subjects.  Each 
subject walked on the treadmill for 5 minutes at 1.7 miles per hour at 0% grade, which 
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generally corresponded to an RPE of 6 to 7 (i.e., “no exertion” to “extremely light”).  
Then, the treadmill was stopped so that the subjects could step off and stretch for 
approximately 5 minutes, targeting particularly the muscles of the hips and legs.   
After the subjects had properly stretched, they stepped back on the treadmill in 
order to start to the exercise trial itself.  The exercise trials were each 9 minutes in 
duration, and were performed at the prescribed intensity for the day.  A duration of 9 
minutes had been chosen a priori based on a pilot test performed on several patients who 
had been currently participating in Get REAL & HEEL, who felt that this was long 
enough for them to be able to complete an exercise trial at intensities between 40% and 
70% of VO2max.  During the exercise trial, the subjects walked or ran on the treadmill 
which was set to the appropriate speed and grade to match the desired intensity for the 
session.  Once the treadmill speed and grade were set, a stopwatch was used to monitor 
time.   Heart rate and RPE were recorded minute-by-minute during the sessions (i.e., 
between 1:50-2:00, 2:50-3:00, 3:50-4:00, etc.) using a Polar heart rate monitor and 
Borg’s RPE scale, respectively. The trials were randomized to prevent an order effect, 
and were blinded to the subjects.   
After the exercise trial had concluded, the subjects entered the cool-down period, 
the purpose of which was to allow the subject’s HR to return to below 120 beats per 
minute, if needed.  At the end of the cool-down period, the treadmill was stopped so that 
the subjects could step off.  The subjects were then seated in a chair so that a finger-prick 
blood sample could be collected, and post-exercise blood lactate could be analyzed using 
a Lactate Plus blood lactate analyzer.  The post-exercise blood lactate was measured after 
the subjects had been seated for 3 minutes, and this was a single specimen analysis.  After 
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analyzing the post-exercise blood lactate, the subjects were allowed to stand up and once 
again stretch the muscles in the hips and legs.   Heart rate was checked to make sure that 
the subjects were clear to leave the facility, or for subjects in the experimental group, to 
continue the rest of their session with a Get REAL & HEEL staff member. 
Instrumentation 
Height and body weight were assessed using a Detecto Model 437 Physician 
Beam Scale (Webb City, MO).  Body fat was analyzed through skinfold measures 
(Pollock 3 site, see Appendix I) using a Lange C-130 Beta Technology calipers 
(Cambridge, MD).  Current physical activity was assessed using the IPAQ (see Appendix 
II).  The Modified Bruce Submaximal Treadmill Protocol was used to predict each 
subject’s VO2max and to calculate the appropriate speed and grade corresponding to 40%, 
60%, and 70% of VO2max for each subject (see Appendix III).  During the initial 
assessment and the exercise trials, a Quinton treadmill was used (Quinton Fitness 
Equipment, Bothell, WA).  Heart rate was measured using a Polar heart rate monitor 
(Lake Success, NY), and RPE was monitored using Borg’s RPE scale (see Appendix IV).  
Post-exercise blood sampling was performed using a lancet, and blood lactate analysis 
was assessed using a hand-held Lactate Plus blood lactate analyzer (Sports Resource 
Group, Hawthorne, NY). 
Statistical Analysis 
All data was gathered and entered into an electronic database for analysis. 
Descriptive statistics are presented in the form of means and standard deviations. All data 
were analyzed on SPSS version 15.0 for Windows, a statistical software program. An 
alpha level of 0.05 was used for all analyses. Each hypothesis was analyzed as follows: 
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 Hypothesis 1):  At a low intensity (40% of VO2max), there will be no significant 
difference in HR response between breast cancer patients and healthy controls during a 9 
minute aerobic exercise bout.  A 2x9 mixed-model ANOVA was used to analyze HR 
response between the experimental group and the control group during the 9 minute 
exercise trial at 40% of VO2max.  If a significant interaction was observed, then post-hoc 
testing of pair-wise comparisons was made using independent samples t-tests. 
 Hypothesis 2):  At a low intensity (40% of VO2max), there will be no significant 
difference in RPE response between breast cancer patients and healthy controls during a 
9 minute aerobic exercise bout.  A 2x9 mixed-model ANOVA was used to analyze RPE 
response between the experimental group and the control group during the 9 minute 
exercise trial at 40% of VO2max.  If a significant interaction was observed, then post-hoc 
testing of pairwise comparisons was made using independent samples t-tests. 
Hypothesis 3):  At a low intensity (40% of VO2max), there will be no significant 
difference in post-exercise blood lactate response between breast cancer patients and 
healthy controls during a 9 minute aerobic exercise bout.  An independent samples t-test 
was used to analyze post-exercise blood lactate response between the experimental group 
and the control group after the 9 minute exercise trial at 40% of VO2max. 
Hypothesis 4):  At a moderate intensity (60% of VO2max), there will be no 
significant difference in HR response between breast cancer patients and healthy controls 
during a 9 minute aerobic exercise bout. A 2x9 mixed-model ANOVA was used to 
analyze HR response between the experimental group and the control group during the 9 
minute exercise trial at 60% of VO2max.  If a significant interaction was observed, then 
post-hoc testing of pair-wise comparisons was made using independent samples t-tests. 
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Hypothesis 5):  At a moderate intensity (60% of VO2max), there will be no 
significant difference in RPE response between breast cancer patients and healthy 
controls during a 9 minute aerobic exercise bout. A 2x9 mixed-model ANOVA was used 
to analyze RPE response between the experimental group and the control group during 
the 9 minute exercise trial at 60% of VO2max.  If a significant interaction was observed, 
then post-hoc testing of pair-wise comparisons was made using independent samples t-
tests. 
Hypothesis 6):  At a moderate intensity (60% of VO2max), there will be no 
significant difference in post-exercise blood lactate response between breast cancer 
patients and healthy controls during a 9 minute aerobic exercise bout. An independent 
samples t-test was used to analyze post-exercise blood lactate response between the 
experimental group and the control group after the 9 minute exercise trial at 60% of 
VO2max. 
Hypothesis 7): At a high intensity (70% of VO2max), breast cancer patients will 
exhibit a significantly higher HR response compared to healthy controls during a 9 
minute aerobic exercise bout. A 2x9 mixed-model ANOVA was used to analyze HR 
response between the experimental group and the control group during the 9 minute 
exercise trial at 70% of VO2max.  If a significant interaction was observed, then post-hoc 
testing of pair-wise comparisons was made using independent samples t-tests. 
Hypothesis 8):  At a high intensity (70% of VO2max), breast cancer patients will 
exhibit a significantly higher RPE response compared to healthy controls during a 9 
minute aerobic exercise bout. A 2x9 mixed-model ANOVA was used to analyze RPE 
response between the experimental group and the control group during the 9 minute 
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exercise trial at 70% of VO2max. If a significant interaction was observed, then post-hoc 
testing of pair-wise comparisons was made using independent samples t-tests. 
Hypothesis 9):  At a high intensity (70% of VO2max), breast cancer patients will 
exhibit a significantly higher post-exercise blood lactate response compared to healthy 
controls after a 9 minute aerobic exercise bout.  An independent samples t-test was used 
to analyze post-exercise blood lactate response between the experimental group and the 
control group after the 9 minute exercise trial at 70% of VO2max.
  
 
CHAPTER IV 
RESULTS  
Subjects 
This thesis study included a total of 14 subjects divided into two groups:  an 
experimental group and a control group.  Subjects in the experimental group were breast 
cancer patients who were post-treatment and were newly-enrolled in the Get REAL & 
HEEL Breast Cancer Program at UNC-Chapel Hill.  All subjects in the experimental 
group underwent surgery, chemotherapy, and radiation therapy during treatment for 
breast cancer.  Four subjects in the experimental group received additional adjuvant 
therapies including Herceptin, Femara, and Tamoxifen.  Three subjects in the 
experimental group had been diagnosed with Stage II breast cancer, and four subjects had 
been diagnosed with Stage III breast cancer.  Subjects in the control group were women 
who had been recruited from the faculty, staff, and student populations at UNC-Chapel 
Hill, had not been enrolled in regular organized physical activity during the past three 
months, had no history of any chronic disease or cancer treatment, and were healthy 
enough to participate in aerobic exercise. Subject characteristics are presented in Table 1.  
Descriptive statistics are presented in the form of mean ± standard deviation.  
Comparisons between the control group and the experimental group were made using 
independent samples t-tests, where appropriate.   
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Table 1.  Subject Characteristics  
Characteristic 
(mean ± SD) 
Control Group 
(n=7) 
Experimental Group 
(n=7) 
p-value 
     Age (years) 46.0  ± 12.4 53.9 ± 6.7 0.164 
     Race  Caucasian (7/7) Caucasian (7/7) -- 
     Menopausal Status      Pre (2/7) 
     Pre/Peri (2/7) 
     Post (3/7) 
     Pre (2/7) 
     Peri (1/7) 
     Peri/Post (1/7) 
     Post (3/7) 
-- 
     Height (cm) 166.2 ± 5.3 166.0 ± 7.3 0.947 
     Weight (kg) 75.8 ± 12.9 72.9 ± 14.1 0.692 
     BMI (kg/m2) 27.5 ± 5.0 26.3 ± 3.6 0.617 
     Percent Body Fat (%) 30.1 ± 4.0 29.3 ± 3.8 0.719 
     Predicted VO2max 
     (mL/kg/min) 
36.4 ± 4.4 32.9 ± 2.2 0.082 
Hypotheses 1-3 
 Hypotheses 1-3 stated that at a low intensity (40% of VO2max), there would be no 
significant difference in either the HR, RPE, or post-exercise blood lactate response 
between breast cancer patients and healthy controls during a 9 minute aerobic exercise 
bout.  Hypotheses 1 and 2 were analyzed using 2x9 mixed-model ANOVAs to compare 
the HR response (Hypothesis 1) and the RPE response (Hypothesis 2) between the 
experimental and the control group during the 9-minute aerobic exercise trial at 40% of 
VO2max. The descriptive statistics (mean ± standard deviation) for the results of the 
analyses of Hypotheses 1 and 2 are presented in Table 2.  The overall results from the 
ANOVA showed that there was no significant group x time interaction for either HR or 
RPE response (p=0.775 and 0.108, respectively).  This indicates that there was no 
significant difference in either HR response or RPE response between the experimental 
group and the control group at any time during the 9 minute aerobic exercise trial at 40% 
of VO2max.   
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Table 2.  Minute-by-Minute Heart Rate and Rate of Perceived Exertion Response during 
the 9 Minute Aerobic Exercise Trial at 40% of VO2max. 
Time 
(minutes) 
Study Group Heart Rate 
(bpm) 
(mean ± SD) 
Rate of Perceived 
Exertion 
(mean ± SD) 
Control 97 ± 10 7 ± 1 1 
Experimental 100 ± 12 8 ± 2 
Control 100 ± 10 7 ± 1 2 
Experimental 102 ± 12 8 ± 2 
Control 100 ± 10 8 ± 1 3 
Experimental 102 ± 9 9 ± 2 
Control 100 ± 10 8 ± 1 4 
Experimental 103 ± 12 9 ± 3 
Control 100 ± 8 8 ± 1 5 
Experimental 102 ± 11 9 ± 3 
Control 102 ± 9 8 ± 1 6 
Experimental 104 ± 11 9 ± 3 
Control 103 ± 8 9 ± 1 7 
Experimental 104 ± 15 9 ± 3 
Control 103 ± 10 9 ± 2 8 
Experimental 103 ± 13 9 ± 3 
Control 104 ± 11 9 ± 2 9 
Experimental 103 ± 12 9 ± 3 
Hypothesis 3 was analyzed using an independent samples t-test to compare the 
post-exercise blood lactate response between the experimental group and the control 
group after the 9 minute aerobic exercise trial at 40% of VO2max.  The descriptive 
statistics (mean ± standard deviation) for the analysis of Hypothesis 3 are presented in 
Table 3.  There was no significant difference in post-exercise blood lactate response 
between the experimental group and the control group following the 9 minute aerobic 
exercise trial at 40% of VO2max (p=0.704). 
Table 3.  Post-Exercise Blood Lactate Response following the 9 Minute Aerobic Exercise 
Trial at 40% of VO2max. 
Study Group Post Exercise Blood Lactate 
(mmol/L) (mean ± SD) 
Control 1.11 ± 0.73 
Experimental 1.26 ± 0.64 
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Hypotheses 4-6 
 Hypotheses 4-6 stated that at a moderate intensity (60% of VO2max), there would 
be no significant difference in either HR, RPE, or post-exercise blood lactate response 
between breast cancer patients and healthy controls during a 9 minute aerobic exercise 
bout.  Hypotheses 4 and 5 were analyzed using 2x9 mixed-model ANOVAs to compare 
the HR response (Hypothesis 4) and the RPE response (Hypothesis 5) between the 
experimental group and the control group during the 9 minute exercise trial at 60% of 
VO2max.  The descriptive statistics (mean ± standard deviation) for the results of the 
analyses of Hypotheses 4 and 5 are presented in Table 4.  The overall results from the 
ANOVA showed that there was a significant group x time interaction for both HR and 
RPE response during the 9 minute aerobic exercise trial at 60% of VO2max (p=0.014 and 
0.039, respectively).  Post-hoc analysis was performed using independent samples t-tests 
to examine pair-wise comparisons of both HR response and RPE response between the 
experimental group and the control group during each minute of the exercise trial. (i.e., 
HR response of the experimental group vs. the control group at Minute 1, HR response of 
the experimental group vs. the control group at Minute 2, etc.).    Based on this analysis, 
no significant pair-wise differences in either HR response or RPE response were found to 
exist between the experimental group and the control group during any minute of the 9 
minute aerobic exercise trial at 60% of VO2max. 
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Table 4.  Minute-by-Minute Heart Rate and Rate of Perceived Exertion Response during 
the 9 Minute Aerobic Exercise Trial at 60% of VO2max. 
Time 
(minutes) 
Study Group Heart Rate 
(bpm) 
(mean ± SD) 
Rate of Perceived 
Exertion 
(mean ± SD) 
Control 112 ± 16 9 ± 2 1 
Experimental 109 ± 10 10 ± 3 
Control 122 ± 18 11 ± 2 2 
Experimental 116 ± 12 10 ± 3 
Control 124 ± 17 11 ± 2 3 
Experimental 117 ± 14 10 ± 3 
Control 127 ± 18 12 ± 2 4 
Experimental 118 ± 13 10 ± 3 
Control 130 ± 18 13 ± 3 5 
Experimental 117 ± 14 10 ± 3 
Control 131 ± 18 13 ± 2 6 
Experimental 119 ± 14 11 ± 3 
Control 132 ± 17 13 ± 2 7 
Experimental 120 ± 14 11 ± 3 
Control 133 ± 18 13 ± 2 8 
Experimental 120 ± 12 11 ± 3 
Control 136 ± 18 14 ± 3 9 
Experimental 121 ± 14 11 ± 3 
Hypothesis 6 was analyzed using an independent samples t-test to compare the 
post-exercise blood lactate response between the experimental group and the control 
group after the 9 minute exercise trial at 60% of VO2max.  The descriptive statistics (mean 
± standard deviation) for the analysis of Hypothesis 6 are presented in Table 5.  There 
was no significant difference in post-exercise blood lactate response between the 
experimental group and the control group following the 9 minute aerobic exercise trial at 
60% of VO2max (p=0.181). 
Table 5.  Post-Exercise Blood Lactate Response following the 9 Minute Aerobic Exercise 
Trial at 60% of VO2max. 
Study Group Post Exercise Blood Lactate 
(mmol/L) (mean ± SD) 
Control 3.83 ± 2.48 
Experimental 2.23 ± 1.65 
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Hypotheses 7-9 
 Hypotheses 7-9 stated that at a high intensity (70% of VO2max), breast cancer 
patients would exhibit significantly higher HR, RPE, and post-exercise blood-lactate 
responses compared to healthy controls during a 9 minute aerobic exercise bout. 
Hypotheses 7 and 8 were analyzed using 2x9 mixed-model ANOVAs to compare the HR 
response (Hypothesis 7) and the RPE response (Hypothesis 8) between the experimental 
group and the control group during the 9 minute exercise trial at 70% of VO2max.  The 
descriptive statistics (mean ± standard deviation) for the results of the analyses of 
Hypotheses 7 and 8 are presented in Table 6.  The overall results from the ANOVA 
showed that there was no significant group x time interaction for HR response during the 
9 minute aerobic exercise trial at 70% of VO2max (p=0.662).  However, there was a 
significant group x time interaction for RPE response during the 9 minute aerobic 
exercise trial at 70% of VO2max (p=0.003).  Post-hoc analysis was performed using 
independent samples t-tests to examine pair-wise comparisons of RPE response between 
the experimental group and the control group during each minute of the exercise trial. 
(i.e., RPE response of the experimental group vs. the control group at Minute 1, RPE 
response of the experimental group vs. the control group at Minute 2, etc.).    Based on 
this analysis, no significant pair-wise differences in RPE response were found to exist 
between the experimental group and the control group during any minute of the 9 minute 
aerobic exercise trial at 70% of VO2max. 
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Table 6.  Minute-by-Minute Heart Rate and Rate of Perceived Exertion Response during 
the 9 Minute Aerobic Exercise Trial at 70% of VO2max. 
Time 
(minutes) 
Study Group Heart Rate 
(bpm) 
(mean ± SD) 
Rate of Perceived 
Exertion 
(mean ± SD) 
Control 130 ± 25 11 ± 2 1 
Experimental 116 ± 13 11 ± 3 
Control 145 ± 26 12 ± 2 2 
Experimental 129 ± 14 12 ± 3 
Control 149 ± 27 13 ± 1 3 
Experimental 135 ± 13 12 ± 3 
Control 152 ± 27 14 ± 1 4 
Experimental 137 ± 14 13 ± 3 
Control 155 ± 27 15 ± 2 5 
Experimental 139 ± 14 13 ± 3 
Control 156 ± 28 15 ± 2 6 
Experimental 140 ± 13 13 ± 3 
Control 157 ± 28 15 ± 2 7 
Experimental 141 ± 13 13 ± 3 
Control 158 ± 28 16 ± 2 8 
Experimental 140 ± 14 13 ± 3 
Control 158 ± 27 16 ± 2 9 
Experimental 142 ± 13 13 ± 3 
Hypothesis 9 was analyzed using an independent samples t-test to compare the 
post-exercise blood lactate response between the experimental group and the control 
group after the 9 minute exercise trial at 70% of VO2max.  The descriptive statistics (mean 
± standard deviation) for the analysis of Hypothesis 9 are presented in Table 7.  The post-
exercise blood lactate response was significantly higher in the control group versus the 
experimental group following the 9 minute aerobic exercise trial at 70% of VO2max 
(p<0.0005). 
Table 7.  Post-Exercise Blood Lactate Response following the 9 Minute Aerobic Exercise 
Trial at 70% of VO2max. 
Study Group Post Exercise Blood Lactate 
(mmol/L) (mean ± SD) 
Control 7.70 ± 1.62 
Experimental 3.29 ± 1.08 
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Summary of Results 
 A summary of results is presented in Table 8.  Brief descriptions of the research 
hypotheses and major outcomes are shown, along with the corresponding p-value.  Based 
on the results of this study, each hypothesis may now be accepted or rejected. 
Table 8.  Summary of Results 
Exercise Trial 
Intensity 
Hypothesis Study Outcome p-value Accept or Reject 
Hypothesis? 
40% of VO2max 1:  No significant 
difference in HR response 
between groups 
No significant 
difference between 
groups 
0.775 Accept 
40% of VO2max 2:  No significant 
difference in RPE 
response between groups 
No significant 
difference between 
groups 
0.108 Accept 
40% of VO2max 3:  No significant 
difference in post-exercise 
blood lactate between 
groups 
No significant 
difference between 
groups 
0.708 Accept 
60% of VO2max 4:  No significant 
difference in HR response 
between groups 
Significant group x 
time interaction 
0.014, but no 
significance 
upon post-hoc 
analysis 
Reject 
60% of VO2max 5:  No significant 
difference in RPE 
response between groups 
Significant group x 
time interaction 
0.039, but no 
significance 
upon post-hoc 
analysis 
Reject 
60% of VO2max 6:  No significant 
difference in post-exercise 
blood lactate between 
groups 
No significant 
difference between 
groups 
0.181 Accept 
70% of VO2max 7:  Experimental group 
will exhibit a significantly 
higher HR response 
No significant 
difference between 
groups 
0.662 Reject 
70% of VO2max 8:  Experimental group 
will exhibit a significantly 
higher RPE response 
Significant group x 
time interaction 
0.003, but no 
significance 
upon post-hoc 
analysis 
Reject 
70% of VO2max 9:  Experimental group 
will exhibit a significantly 
higher post-exercise blood 
lactate response 
Control group 
exhibited 
significantly higher 
response 
 
<0.0005 Reject 
  
 
CHAPTER V 
DISCUSSION 
The purpose of this study was to compare the HR, RPE, and post-exercise blood 
lactate response to low, moderate, and high intensity aerobic exercise in post-treated 
breast cancer patients and healthy controls.  During the course of this study, subjects 
completed an initial assessment to determine their predicted VO2max from a Modified 
Bruce Protocol on the treadmill.  The results of the initial assessment were used to 
calculate the speed and grade that corresponded to 40%, 60%, and 70% of predicted 
VO2max.  Subjects then completed three 9-minute aerobic exercise trials, one at each 
intensity, in random order.  During each trial, HR and RPE data were collected during the 
last 10 seconds of every minute, and blood lactate was collected 3 minutes post-trial.  The 
HR and RPE data were analyzed using 2x9 mixed-model ANOVAs, and post-hoc 
analyses were carried out using independent samples t-tests, where appropriate.  The 
post-exercise blood lactate data were analyzed using independent samples t-tests. 
Heart Rate, RPE, and Post-exercise Blood Lactate Response at 40% of VO2max 
 Hypotheses 1-3 stated that at a low intensity (40% of VO2max), there would be no 
significant difference in either the HR, RPE, or post-exercise blood lactate response 
between breast cancer patients and healthy controls during a 9 minute aerobic exercise 
bout.  The results of this study support these hypotheses, indicating that the physiological 
and perceived exertion responses are similar between the experimental group and the 
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control group during short-duration, low-intensity aerobic exercise (HR response: 
p=0.775; RPE response:  p=0.108; post exercise blood lactate response:  p=0.708).   
Heart Rate, RPE, and Post-exercise Blood Lactate Responses at 60% of VO2max 
 Hypotheses 4-6 stated that at a moderate intensity (60% of VO2max), there would 
be no significant difference in either HR, RPE, or post-exercise blood lactate response 
between breast cancer patients and healthy controls during a 9 minute aerobic exercise 
bout.  The results showed that there was a significant group x time interaction for HR and 
RPE response (p=0.014, 0.039, respectively).  However, post-hoc analysis, minute-by-
minute comparisons between the control group and the experimental group for HR and 
RPE response only occurred in the comparisons that were not of relevance to this study 
(i.e., HR response at minute 1 for the control group vs. HR response at minute 9 for the 
experimental group).  As for the analyses of blood concentration between groups, again, 
no significant difference was observed between the two groups (p=0.181).   
 Even though the post-hoc analyses did not show differences in the pair-wise 
comparisons of HR and RPE response relevant to the hypotheses tested in this study, the 
mean differences observed minute-by-minute for HR and RPE may be of clinical 
relevance. However, according to this study design, many methodological challenges 
were faced by the investigators during this experiment may somewhat explain these 
differences.  Firstly, the small sample size could have been one of the major limitations in 
the analysis.  Secondly, some subjects held the handrails on the treadmill while others did 
not.  More specifically, 5 of the 7 experimental subjects held the handrails while only 2 of 
the 7 control subjects held the handrails.  By holding the handrails, it is likely that the 
subjects did not have to work as hard to keep up with the treadmill belt as it was moving.  
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Since it was mainly the experimental group that used the handrails, this may have 
contributed to the lower HR and RPE response observed for this group.  While post-
exercise blood lactate response was not significantly different between the groups, the 
experimental group did have a lower mean level than did the control group (3.83 mmol/L 
vs. 2.23 mmol/L), which may also be due in part to the use of the treadmill handrails.  
During this study, all attempts were made to standardize the protocols used during the 
initial assessment and during each aerobic exercise trial, but as the study progressed, it 
became evident that some subjects could not safely or comfortably walk on the treadmill 
without using the handrails.  However, if a subject held the handrails during the initial 
assessment, then they were instructed to hold the rails for the subsequent aerobic exercise 
trials. 
 A third possible reason why the control group displayed a higher HR and RPE 
response during the exercise trial may be related to the age difference between the two 
groups. The mean age difference between the control group and the experimental group 
was not statistically significant (p=0.164); however, the experimental group was older 
than the control group by 7.9 years. It is known that HR decreases with age during 
submaximal exercise at a relative exercise intensity (Brooks et al., 2005, p. 839).  Muscle 
biochemistry also changes with age, including decreases in glycolytic enzymes (Brooks 
et al., 2005, p. 844).  This includes the enzyme lactate dehydrogenase (LDH), which is 
responsible for the production of lactic acid, especially during more intense exercise 
(Brooks et al., 2005, p. 844).  Since the experimental group is older than the control 
group, this may also explain why HR and post-exercise blood lactate were lower in this 
group.  The small sample size may have also contributed to the statistically non-
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significant difference in mean age between the groups.  If the sample size were larger, it 
is possible that a mean difference of 7.9 years could present a different result. 
Heart Rate, RPE, and Post-exercise Blood Lactate Responses at 70% of VO2max 
Hypotheses 7-9 stated that at a high intensity (70% of VO2max), breast cancer 
patients would exhibit significantly higher HR, RPE, and post-exercise blood-lactate 
responses compared to healthy controls during a 9 minute aerobic exercise bout.  The 
results showed that there was no significant group x time interaction in HR response.  
There was a significant group x time interaction for RPE response (p=0.003).  Post-hoc 
analysis, minute-by-minute comparisons between the control group and the experimental 
group for RPE response, as was the case for the moderate intensity trial, indicated that the 
significant pair-wise differences in RPE response occurred for comparisons that were not 
of relevance for this study.  There was a significant difference in post-exercise blood 
lactate between the control group and the experimental group, with the control group 
exhibiting a higher response (p<0.0005). 
The fact that there was no significant difference in HR or RPE response during 
the trial at 70% of VO2max was surprising; however, methodological reasons may have 
again influenced the results.  As was the case during the moderate intensity trial, 5 of the 
7 experimental subjects held the handrails on the treadmill while only 2 of the 7 control 
subjects used the handrails.  Even though no statistical significance was observed for HR 
response between the groups, the differences in mean HR response throughout the 9 
minutes ranged from 14-18 bpm, with the control group exhibiting the higher HR 
response.  Additionally, the standard deviations surrounding the mean HR response for 
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the control group was twice as large as those for the experimental group, which may have 
also contributed to the non-significant findings.   
Another factor that may have contributed to the results for HR and RPE response 
was the fact that 4 of the 7 control subjects ran for the duration of the trial, while all of 
the experimental subjects walked.  These 4 subjects did not hold the handrails during the 
exercise trial, and these 4 subjects also had a predicted VO2max greater than the mean for 
the control group.  As such, these 4 subjects were required to perform this exercise trial at 
a speed of 4.2-5.2 mph.  This is quite a fast pace for most people to walk, so it is not 
surprising that these subjects had to run during the trial.  It should be noted that one of the 
control subjects who held the handrail did walk at a speed of 4.1 mph; however, had she 
not held the handrail, it is likely that she would have not been able to walk that fast, and 
would have needed to run during the trial.  The differences in running vs. walking, as 
well as whether or not the subjects held the handrails may have also contributed to the 
significant RPE findings, where the control subjects reported higher RPE scores than did 
the experimental group. 
A third factor that may have contributed to the findings for HR and RPE response 
during the exercise trial at 70% of VO2max, may have involved the method that was used 
to calculate intensity.  The Modified Bruce Protocol, which was used during the initial 
VO2max assessment, terminates at 75% of HRR.  In reality, 75% of HRR is a lower 
intensity than 75% of VO2max.  Therefore, when using the results of the Modified Bruce 
Protocol to calculate the treadmill speed and grade that would correspond to 70% of 
VO2max, it is possible that subjects may have been exercising at an intensity higher than 
70% of VO2max.  
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The significant difference in post-exercise blood lactate response was surprising, 
in that it was not expected that the control group would exhibit a higher response than the 
experimental group.  Many of the factors previously discussed, as well as the mean age 
difference between the two groups, may have contributed to the higher lactate response in 
the control group.  Additionally, the action of running, compared to walking, requires the 
use of more Type II muscle fibers, which have significant glycolytic capacity and 
therefore produce lactate in response to higher intensity exercise.  However, a mean diff 
of 4.41 mmol/L between the two groups is intriguing, and it is possible that there are 
other physiological mechanisms occurring that may have caused the differences in lactate 
response.  The literature describing the effect of cancer treatment on the production of 
lactate in skeletal muscle is extremely scarce; therefore, it is early to believe that the 
experimental subjects are in fact producing less lactate than age-matched controls of 
similar cardiopulmonary fitness.   
Application of Results to Aerobic Exercise Prescription in Breast Cancer Patients 
As stated before, the purpose of this experiment was to compare the HR, RPE, 
and post-exercise blood lactate response to low, moderate, and high intensity aerobic 
exercise in post-treated breast cancer patients and apparently healthy controls.  Changes 
in physiological /psychological function over the duration of a long-term exercise 
program were not assessed; therefore, this study does not really attempt to evaluate 
whether 40%, 60%, and 70% of VO2max are intensities that are truly appropriate for 
exercise prescription in the breast cancer patient population.  However, the results of this 
study may begin to shed some light on how post-treated breast cancer patients respond to 
acute bouts of low, moderate, and high intensity aerobic exercise compared with 
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individuals who have never been through major cancer treatment.  As more studies are 
conducted, this knowledge will be useful when assessing the appropriateness of different 
intensities in order to formulate safe and effective exercise prescriptions for this 
population. 
The results of the exercise trials at 40% and 60% of VO2max indicate that the 
experimental group responded similarly to the control group with respect to HR, RPE, 
and post-exercise blood lactate.  During the exercise trial at 70% of VO2max, the 
experimental group again responded similarly to the control group with respect to HR 
and RPE response, and the post-exercise blood lactate response was significantly lower in 
the experimental group.  These results may infer that it could be appropriate to use a wide 
range of intensities similar to those used for healthy adult, cardiac patient, and elderly 
adult populations when formulating exercise prescriptions for post-treated breast cancer 
patients.  A closer look at the results of the exercise trial at 60% of VO2max showed that 
the levels of exertion reported by the experimental group seemed to be tolerable (mean 
RPE range of 10-11 or “light”), and the subjects did not report any extreme difficultly, 
when exercising on the treadmill holding the hand rails.  Therefore, it is likely that the 
subjects would be able to continue at this intensity for an extended period of time before 
volitional fatigue.  Similarly, the subjects in the experimental group seemed to tolerate 
the exercise trial at 70% of VO2max for the 9 minute period without adverse effects, but it 
is possible that they may not have been able to maintain that intensity for much longer.  
This is suggested by the mean RPE scores for the experimental group for each minute of 
the trial, which ranged from 11 to 13 (“light” to “somewhat hard”) with standard 
deviations of ± 3 around the mean RPE scores of 13, as well as from anecdotal feedback 
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from subjects in the experimental group.  It is also important to note that the subjects 
within the experimental group were within 6 months of completion of major cancer 
treatment.  Patients who are currently undergoing in-hospital treatment, or who are 
suffering from more severe side effects may not respond the same way the subjects in the 
current study did; nor might they be able to tolerate an intensity of 60% of VO2max.  
Therefore, the results of this study should be interpreted cautiously, especially when 
considering intensities of above 60% of VO2max. 
The existing literature reporting the effects of aerobic exercise in the breast cancer 
patient population is encouraging, in that aerobic exercise of various intensities seems to 
elicit many positive responses in physiological and psychological parameters.  When 
considering low intensity aerobic exercise, Dimeo et al. (1997, 1999) investigated the 
effects of physical exercise on physical performance, severity of treatment complications, 
and psychological distress in cancer patients, using an exercise intensity of 50% of HRR, 
which may be similar to 40% of VO2max.  In the first study, 70 patients (including 46 
breast cancer patients) participated in an exercise sessions that included alternating bouts 
of 1 minute of cycling and 1 minute of rest, for a total of 30 minutes.  In the second 
study, 59 patients (including 31 breast cancer patients) participated in an exercise 
program that included the same type of interval cycling.  Both studies revealed positive 
results, including increased physical performance and decreased thrombopenia, 
neutropenia, psychological distress, and time spent in the hospital.  In a study by 
Battaglini et al. (2004), a group of 27 patients including 22 breast cancer patients 
participated in an exercise program where aerobic exercise intensity was set between 50-
55% of maximal heart rate, which may also be similar to 40% of VO2max. The goal of the 
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study was to examine the relationship between changes in selected physiological 
parameters and fatigue during a period of 6 months. Even though no significant 
relationship between selected physiological parameters including % body fat, resting 
heart rate, and dynamic endurance tests, an improvement in cardiorespiratory endurance 
of approximately 30% was observed with no adverse effects of the intensity used being 
reported.   
Moving towards the literature examining the effect of moderate aerobic intensity 
on breast cancer patients, another study by Battaglini et al. (2006) investigated the 
exercise response in a group of 20 breast cancer patients undergoing treatment. Patients 
assigned to the exercise group, participated in a structured exercise program at an 
intensity range between 40-60% of VO2max, for a period of approximately 21 weeks. No 
adverse effects of the intensity used in the Battaglini et al. study were reported. 
Furthermore, significant decreases in fatigue were observed in the exercise group when 
compared to the control group at the end of the first, second, and final bout of 
chemotherapy treatment (p=0.001, p=0.005, and p=0.001 respectively).  Segal et al. 
(2001) investigated the effect of a self-paced walking intervention along with a 
supervised exercise program at 50-60% of VO2max on health-related quality of life in 123 
breast cancer patients.  Increases in physical functioning, measured by the Short Form 
(SF)-36 scale were observed after 26 weeks of exercise intervention.  In patients who did 
not receive chemotherapy, aerobic capacity was significant increased and body weight 
was significantly decreased (p=0.01 and <0.05, respectively) in patients participating in 
supervised exercise compared with patients receiving usual care.   
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Several studies have used intensities of 70% of VO2max and above to examine the 
impact of exercise on various endpoints in breast cancer patients.  Fairey et al. (2003, 
2005a, 2005b) conducted three studies examining the effect of exercise training on 
several blood markers including fasting insulin, insulin resistance, insulin growth factors, 
insulin growth factor binding proteins, NK cell cytotoxic activity, C-reactive protein, and 
various cardiovascular disease risk factors.  Fifty-two post-menopausal post-treated 
breast cancer patients participated in an exercise program that included cycling at 70-75% 
of VO2peak.  Patients trained 3 times per week for 15 weeks, starting with a duration of 15 
minutes during weeks 1-3 and increasing by 5 minutes every 3 weeks thereafter up to a 
total of 35 minutes for weeks 13-15.  Positive changes were observed for cardiovascular 
function and disease risk factors, including increased VO2max, and decreased C-reactive 
protein, resting HR, HRR, blood pressure, and HDL-C.  An increase in NK cell activity 
was also observed as well as changes in levels of insulin-like growth factors and insulin-
like growth factor binding proteins.  Kim et al. (2006) studied cardiopulmonary responses 
and adherence to exercise after an 8-week exercise intervention in 41 post-treated breast 
cancer patients.  Patients participated in supervised aerobic exercise at an intensity of 60-
70% VO2peak and/or HRR for 30 minutes per day, 3 days per week.  Activities consisted 
of cycling, walking, or jogging on a treadmill.  The results showed that patients 
participating in exercise had decreased resting HR, resting systolic blood pressure, and an 
increased VO2peak.  Patients also reported an increase in voluntary activity, a decrease in 
sedentary activity.  Courneya et al. (2007) conducted a multicenter trial to study the 
effects of exercise on body composition, physical function, and quality of life.  The study 
included 78 breast cancer patients who performed aerobic exercise at an intensity range 
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of 60-80% of VO2max, using the treadmill, elliptical, and cycle ergometer.  Patients 
participated in an exercise program for 3 days per week for the duration of their 
chemotherapy regimen, plus 2 weeks before and 3 weeks afterwards.  Exercise duration 
began at 15 minutes during weeks 1-3, and it increased by 5 minutes every 3 weeks until 
the total duration reached 45 minutes.  During weeks 1-6, patients exercised at 60% of 
VO2max, which progressed to 70% of VO2max during weeks 7-12, and then to 80% of 
VO2max beyond week 12.  Increases in aerobic fitness and self esteem, and improved body 
composition and chemotherapy completion rate without causing lymphadema or other 
significant adverse events were observed.   
Therefore, according to the current literature, physiological responses to aerobic 
exercise comparable to the intensities used in the current study seem to be well-tolerated 
by the breast cancer patient population, while also attaining positive changes in 
physiological and psychological parameters.  Even though no significant adverse effects 
were observed in the studies cited above, several investigators used intensities that were 
quite high, and therefore these results should be interpreted cautiously, particularly when 
considering the potential impact of high intensity aerobic exercise on the immune system 
in breast cancer. Very few studies have examined the impact of exercise on immune 
markers and therefore, up to now, the results of these studies are somewhat inconclusive. 
Also, according to the results of the Segal et al. (2001) study, the type of treatment, phase 
of treatment, and the level of side effects experienced should all be taken into 
consideration before prescribing exercise dosage.   
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Limitations 
This is the first study that has attempted to understand the physiological responses 
to various levels of aerobic exercise intensity in post-treated breast cancer patients, 
compared with apparently healthy age-matched controls that have never gone through 
treatment for breast cancer.  Many challenges were faced during this experiment, which 
may have impacted our results.  These limitations should be addressed in order to 
precisely understand the impact of different intensities on the physiology of these 
patients.   
The first limitation of this study is the small sample size.  There were 7 subjects in 
the experimental group and 7 subjects in the control group, and while statistically 
significant differences in some physiological parameters were observed between the 
groups, it is difficult to know whether these differences would persist with a larger 
sample size.  Similarly, it is difficult to know whether the statistically non-significant 
differences that were observed between the groups would still be non-significant with the 
addition of more subjects. 
The second limitation of this study is the difference in the mean ages of the 
groups.  The mean age of the experimental group was 53.9 years, and the mean age of the 
control group was 46.0 years, which is a mean difference of 7.9 years.  This difference 
was not statistically significant (p=0.164); however, the older age of the experimental 
group may have contributed to the lower HR responses observed in this group during the 
trials at 60% and 70% of VO2max. 
A third limitation of this study was that some subjects walked on the treadmill 
using the handrails while some did not.  While every attempt was made to standardize the 
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protocol, it became evident that some subjects were not able to comfortably or safely 
walk on the treadmill without holding the handrails.  Since it was mainly the 
experimental group that used the handrails, it may still be difficult to compare the 
physiological responses between the two groups, and this may partially account for the 
attenuated HR, RPE, and post-exercise blood lactate responses in the experimental group 
during the moderate and high-intensity aerobic exercise trials. 
A fourth limitation of this study was the protocol during the initial assessment to 
predict VO2max, as well as the method used to calculate predicted VO2max.  The Modified 
Bruce Protocol was chosen for this study because it is the same protocol that is currently 
used to assess cardiopulmonary endurance of participants in the Get REAL & HEEL 
Breast Cancer Program; therefore, it was familiar to the investigators, and it would be 
used to re-assess the subjects in the experimental group throughout their time as 
participants in Get REAL & HEEL.  Additionally, the Modified Bruce Protocol is 
recommended for use in high risk, cardiac patient, and elderly adult populations; 
therefore, it should be a suitable protocol to use with post-treated breast cancer patients 
(Heyward, 2006, p. 67).  As mentioned previously, the test terminates when the subject 
reaches a THR of 75% of HRR.  Since an intensity of 75% of HRR is most likely lower 
than an intensity of 75% of VO2max, the mathematical formula used to determine the 
intensities for the aerobic exercise trials may not have been entirely accurate, particularly 
when determining the treadmill speed and grade for the high-intensity exercise trial.   
The following equation was used to calculate predicted VO2max: 
VO2max = 2.282*(total time on treadmill) + 8.545 
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This equation is currently used at Get REAL & HEEL, as recommended by the Rocky 
Mountain Cancer Rehabilitation Institute (Schneider, Dennehy, Roozeboom & Carter, 
2002), to calculate predicted VO2max during cardiopulmonary physiological assessments, 
and it is recommended for use in the cardiac patient and elderly adult populations 
(Heyward, 2006, p. 68).  However, this prediction equation was mostly intended for use 
when the subject is holding the handrails while walking on the treadmill (Heyward, 2006, 
p. 68).  Since not all subjects held the handrails, this equation may not have been the most 
appropriate choice for calculating predicted VO2max. 
A fifth limitation of this study was that some subjects in the experimental group 
had been considered post-treated for a longer time period than others (all were within 6 
months of completion of major cancer treatment).  It is possible that patients who have 
just finished treatment may experience side effects to a higher degree than those who 
have been finished with treatment for a longer period of time.  Future studies should 
control for this; for example, a post-treatment window of 1-2 months rather than a 
window of 6 months should be used. 
A sixth limitation of this study may have related to the amount of time that the 
control group had been considered sedentary before enrolling onto the study.  As 
mentioned in the Methodology, the control subjects who had not participated in regular 
organized physical activity during the past 3 months were eligible for this study.  While 
this was true for all subjects in the control group, 4 of these subjects did have a prior 
history of being physically active, either as a recreational or competitive athlete, and it 
was these same 4 subjects who ran for the duration of the exercise trial at 70% of VO2max.  
It is possible that some of the physiological adaptations experienced during previous 
 61 
training may still exist, even if the subject is currently sedentary.  For this reason, it may 
be better to use control subjects who have been physically inactive for at least 1 year for 
future studies.  Also, a longer period of not participating in regular physical activity 
beyond the 3-month criteria used in the current study should be revised.  
An eighth limitation of this study may have related to the menopausal status and 
menstrual cycle phase of the subjects during the completion of the exercise trials.  High 
levels of estrogen decreases carbohydrate metabolism and increases lipid metabolism; 
therefore, women who are in the luteal phase of the menstrual cycle experience decreased 
glucose oxidation and consequently lower lactate production during exercise (Brooks et 
al., 2005, p. 790).  On the other hand, women who are experiencing oligomenorrhea or 
amenorrhea due to the onset of menopause, have decreased levels of estrogen, and 
therefore increased carbohydrate metabolism and lactate production during exercise.  It is 
possible that the differences in menopausal status between subjects, as well as menstrual 
cycle phase, may have also contributed to the post-exercise blood lactate results of the 
two study groups in response to the exercise trials. 
Recommendations for Future Studies 
The basis for the current study is the need to better understand the impact of 
exercise intensity in breast cancer patients so that prescriptions can be made more safely 
and efficiently.  Prescriptions for cancer patients are variable and should be 
individualized based on the physiological state of the patient prior to each session.  
Furthermore, while the impact of exercise on immune function in breast cancer patients is 
not clearly understood, it is known that exercise can act as a stressor on the body’s 
physiological systems, including the immune system.  Since some breast cancer patients 
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may be starting an exercise program with compromised immune function, it is important 
to ensure that the exercise prescription does not further suppress the immune system, but 
instead, helps to stimulate recovery.  Therefore, the need for a better understanding of 
aerobic exercise intensity is paramount. 
In light of the limitations previously mentioned, some recommendations for future 
studies are provided below.   
1. A larger sample size of patients and controls should be obtained so that the impact 
of aerobic exercise intensity can be evaluated in a greater number of individuals.   
2. Subjects in the experimental and control groups should be age-matched more 
closely.  Additionally, a smaller age range should be used (i.e. 40-50 years of age 
rather than 30-75 years of age).  This may help to minimize the effect of age 
differences on cardiovascular responses and lactate production during exercise.  
3. A more accurate assessment of menopausal status should be considered, since 
estrogen levels may impact the carbohydrate metabolism and the production of 
lactate during exercise.  Similarly, menstrual cycle phase should be controlled for 
more closely when scheduling the exercise trials. 
4. Since some subject held the handrails on the treadmill while others did not, it may 
be best to recommend that all subjects hold the handrails during the initial VO2max 
assessment, as well as during the individual exercise trials.  This may help to 
further standardize the testing protocol, as well as to ensure that all subjects feel 
as safe and comfortable as possible.  Alternatively, a cycling protocol such as the 
YMCA Cycle Ergometer Test could be used in order to predict VO2max, with 
subsequent exercise sessions taking place on a cycle ergometer.  By using a 
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cycling protocol, all subjects would be required to perform the same technique for 
each session; i.e., there would be no discrepancies concerning running vs. 
walking, or holding vs. no holding handrails.   
5. A post-treatment window of 1-2 months, rather than 6 months should be 
considered when recruiting experimental subjects in order to more closely control 
for the type and severity of side effects experienced by the experimental group 
which may affect performance during the initial assessment and exercise trials.  
6. A window of physical inactivity of at least 1 year, should be considered when 
recruiting control subjects in order to more closely control for potential 
physiological changes from previous exercise training. 
7. Since the termination intensity for the initial VO2max assessment was lower than 
the highest intensity used during the exercise trials, it may be more useful to 
perform a VO2peak test to more accurately determine baseline cardiopulmonary 
fitness and to calculate workloads to be used for the different intensities during 
the aerobic exercise trials.  If this option were chosen, all subjects should be 
thoroughly screened for any medical contraindications to completing a VO2peak 
test, and HR, RPE, blood pressure, and a 12-lead ECG should be recorded during 
and after the test (Heyward, 2006, p 60).  Additionally, the presence of a 
physician would be necessary, which would follow the recommendation of the 
ACSM when administering VO2max tests in clinical populations (Whaley et al., 
2006, p. 29).  Since expired gases are collected during a VO2peak test, patients may 
feel more comfortable wearing a mask rather than a mouthpiece. 
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Once studies have been conducted that help clarify the impact of aerobic exercise 
intensity on post-treated breast cancer patients, studies utilizing patients who are 
undergoing treatment should be considered.  Knowing that HR during treatment varies 
tremendously from day to day, confirming the results of this experiment plus exploring 
the possibility of using other quantifiers for aerobic exercise may be of importance. 
Conclusion 
 Low, moderate and high-intensity aerobic exercise does not seem to elicit 
significant differences in HR or RPE response in breast cancer patients compared with 
apparently-healthy controls.  Likewise, low and moderate intensity aerobic exercise does 
not seem to elicit significant differences in post-exercise blood lactate response; however, 
controls had a significantly higher response after high-intensity aerobic exercise.  Small 
sample size, methodological issues and mean age difference between the two groups may 
have contributed to the differing physiological responses seen in this study.  It appears 
that exercise intensities of 40% and 60% of VO2max are tolerable to use when prescribing 
exercise for breast cancer patients, even more so when exercising while holding the 
handrails on a treadmill.  However, it is unclear whether exercise intensities of 70% of 
VO2max are appropriate to use when prescribing exercise for breast cancer patients, 
particularly when considering the possible impact of high intensity aerobic exercise on 
the immune system.  Further investigation with a larger sample size and a more 
standardized protocol is needed in order to better understand the impact of aerobic 
exercise intensity on the physiological function of breast cancer patients compared with 
healthy controls.  Such an understanding will aid in the development of guidelines that 
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are both safe and effective in improving physical function in breast cancer patients after 
the completion of major cancer treatment. 
Appendix I 
Pollock 3-site method for measuring skinfold thickness 
Skinfold Measurement Sites for Women 
1. Measure sites in triplicate 
Triceps):  Vertical fold over triceps, halfway between the shoulder and the elbow. 
Abdomen):  Horizontal fold 3 cm lateral and 1cm inferior to the umbilicus. 
Suprailiac):  Diagonal fold posterior to the midaxillary line and superiorly to the 
iliac crest along the natural cleavage of the skin. 
Thigh):  Vertical fold on the front of the thigh, halfway between the knee and 
inguinal fold 
2.  Average the two closest measurements for each site 
3.  Sum the three averages (triceps, abdomen, suprailiac, or triceps, suprailiac, thigh). 
4.  If using triceps, abdomen, and suprailiac sites, calculate Percent Body Fat using the 
equation below. (Whaley et al., 2006, p. 62) 
Computation of Percent Body Fat (Triceps, Abdomen, Suprailiac Sites) 
% Body Fat = [0.41563*(sum of skinfolds)] – [0.00112*(sum of skinfolds)2] + 
[0.03661*(age)] + 4.03653 
5.  If using triceps, suprailiac and thigh sites, calculate Body Density, then Percent Body 
Fat using the equations below. 
Computation of Body Density Equation for Women (Triceps, Suprailiac, Thigh Sites) 
Body Density = 1.0994921 – [0.0009929*(sum of skinfolds)] + [0.0000023*(sum of 
skinfolds)2] – [0.0001392*(age)] 
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Computation of Percent Body Fat 
% Body Fat = [(4.95/(Body Density)) – 4.500]*100 
(Whaley et al., 2006, p. 63) 
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Appendix II 
International Physical Activity Questionnaire (IPAQ) 
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Appendix III 
Modified Bruce Submaximal Treadmill Protocol 
Test Termination 
The test is terminated when the subject reaches a target heart rate (THR), which is 75% 
of the subject’s heart rate reserve using the Karvonen Formula. 
THR = [(220 – Age) – Resting HR]*0.75 + Resting HR 
Table of Protocol Stages 
Stage Time 
(min) 
Speed 
(mph) 
Grade (%) HR RPE Total Time 
Spent in Stage 
Warm-up 3 1.7 0    
1 3 1.7 5    
2 3 1.7 10    
3 3 2.5 12    
4 3 3.4 14    
5 3 4.2 16    
6 3 5.0 18    
 
Formula to calculate VO2max 
VO2max = 2.282*(total time, in minutes) + 8.545 
Formula to calculate VO2, speed, and grade for the aerobic exercise trials 
Horizontal VO2 (in mL/kg/min) = speed (in m/min) * (0.1 mLO2/kg/min) 
Vertical VO2 (in mL/kg/min) = % grade * speed (in m/min) * (1.8 mLO2/kg/min) 
Rest VO2 = 3.5 mL/kg/min 
Total VO2 = Horizontal VO2 + Vertical VO2 + Rest VO2 
Conversion Factor 
1 mph = 26.8 m/min 
(Heyward, 2006, p. 64, 68)
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Appendix IV 
Borg’s Rate of Perceived Exertion Scale 
 
 
6 No exertion at all 
7 Extremely light 
8  
9 Very light 
10  
11 Light 
12  
13 Somewhat hard 
14  
15 Hard (heavy) 
16  
17 Very hard 
18  
19 Extremely hard 
20 Maximal exertion 
 
(Borg, 1982)
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